Role of personality disorder in randomised controlled trials of pharmacological interventions for adults with mood disorders: a protocol for a systematic review and meta-analysis
Open accessAbstract
Introduction: Remission rates for mood disorders, including depressive and bipolar disorders, remain relatively low despite available treatments, and many patients fail to respond adequately to these interventions. Evidence suggests that personality disorder may play a role in poor outcomes. Although personality disorders are common in patients with mood disorders, it remains unknown whether personality disorder affects treatment outcomes in mood disorders. We aim to review currently available evidence regarding the role of personality disorder on pharmacological interventions in randomised controlled trials for adults with mood disorders. Methods and analysis: A systematic search of Cochrane Central Register of Controlled Clinical Trials (CENTRAL) via cochranelibrary.com, PubMed via PubMed, EMBASE via embase.com, PsycINFO via Ebsco and CINAHL Complete via Ebsco databases will be conducted to identify randomised controlled trials that have investigated pharmacological interventions in participants aged 18 years or older for mood disorders (ie, depressive disorders and bipolar spectrum disorders) and have also included assessment of personality disorder. One reviewer will screen studies against the predetermined eligibility criteria, and a second reviewer will confirm eligible studies. Data will be extracted by two independent reviewers. Methodological quality and risk of bias will be assessed using the Cochrane Risk of Bias tool. A systematic review, and if sufficient evidence is identified, a meta-analysis will be completed. Meta-analysis will be conducted using the standardised mean difference approach and reported with 95% CIs. A random effects model will be employed and statistical heterogeneity will be evaluated using the I 2 statistic. Prespecified subgroup analyses will be completed. Ethics and dissemination: As this systematic review will use published data, ethics permission will not be required. The outcomes of this systematic review will be published in a relevant scientific journal and presented at a research conference. Trial registration number: CRD42018089279.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
For people recovering from psychotic depression, continuing the antipsychotic medication over several months at least is needed in order to prevent relapse and recurrence.
“For people recovering from psychotic depression, continuing the antipsychotic medication over several months at least is needed in order to prevent relapse and recurrence. 555”
From Time for united action on depression: a Lancet–World Psychiatric Association Commission (2022) · cites this paper as [555]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369 · see citing works
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823 · see citing works
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042 · see citing works
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139 · see citing works
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859 · see citing works
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Higgins, J. P. T., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., Sterne, J. A. C., et al. (2011) · BMJ · doi:10.1136/bmj.d5928 · Cited by 33,817 · see citing works
PRISMA-P Group, Moher, D., Shamseer, L., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Shekelle, P., & Stewart, L. A. (2015) · Systematic Reviews · doi:10.1186/2046-4053-4-1 · Cited by 26,223 · see citing works
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,577 · see citing works
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305 · see citing works
Wang, G., Ma, R., Qiao, G., Wada, K., Aizawa, Y., & Satoh, T. (2015) · Integrative Medicine International · doi:10.1159/000368408 · Cited by 18,759 · see citing works
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962 · see citing works
Shamseer, L., Moher, D., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Shekelle, P., Stewart, L. A., & the PRISMA-P Group (2015) · BMJ · doi:10.1136/bmj.g7647 · Cited by 13,120 · see citing works
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643 · see citing works
(1997) · American Psychiatric Press eBooks · Cited by 3,056 · see citing works
Estimating the true global burden of mental illness
Vigo, D., Thornicroft, G., & Atun, R. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00505-2 · Cited by 2,494 · see citing works
Intention-to-treat concept: A review
Gupta, S. (2011) · Perspectives in Clinical Research · doi:10.4103/2229-3485.83221 · Cited by 1,921 · see citing works
(1993) · PubMed · Cited by 1,900 · see citing works
The global burden of disease, 1990–2020
López, A. D., & Murray, C. C. J. L. (1998) · Nature Medicine · doi:10.1038/3218 · Cited by 1,613 · see citing works
Manic-Depressive Illness: Bipolar Disorders and Recurrent Depression
Goodwin, F. K., & Jamison, K. R. (2007) · Medical Entomology and Zoology · Cited by 1,325 · see citing works
Loranger, A. W. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030051005 · Cited by 1,069 · see citing works
Rush, A. J. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.11.1905 · Cited by 879 · see citing works
The prevalence of DSM-IV personality disorders in psychiatric outpatients
Zimmerman, M., Rothschild, L., & Chelminski, I. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.10.1911 · Cited by 825 · see citing works
Gunderson, J. G. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.37 · Cited by 770 · see citing works
Bowden, C. L. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.5.481 · Cited by 678 · see citing works
Zanarini, M. C., Frankenburg, F. R., Hennen, J. A., & Silk, K. R. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.2.274 · Cited by 672 · see citing works
Tohen, M. F. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810240026005 · Cited by 538 · see citing works
Personality disorder and the outcome of depression: Meta-analysis of published studies
Newton-Howes, G., Tyrer, P., & Johnson, T. (2006) · British Journal of Psychiatry · doi:10.1192/bjp.188.1.13 · Cited by 537 · see citing works
Moran, P., Leese, M., Lee, T., Walters, P., Thornicroft, G., & MANN, A. H. (2003) · The British Journal of Psychiatry · doi:10.1192/bjp.183.3.228 · Cited by 449 · see citing works
DSM-IV personality disorders in the WHO World Mental Health Surveys
Huang, Y., Kotov, R., de Girolamo, G., Preti, A., Angermeyer, M., Benjet, C., Demyttenaere, K., de Graaf, R., Gureje, O., Karam, A. N., et al. (2009) · British Journal of Psychiatry · doi:10.1192/bjp.bp.108.058552 · Cited by 367 · see citing works
Personality Pathology and Treatment Outcome in Major Depression: A Review
Mulder, R. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.3.359 · Cited by 355 · see citing works
Epidemiology of Personality Disorders
Lenzenweger, M. F. (2008) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2008.03.003 · Cited by 349 · see citing works
Weisler, R. H., Kalali, A. H., Ketter, T. A., & SPD417 Study Group (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0405 · Cited by 349 · see citing works
The Personality Diagnostic Questionnaire: Development and Preliminary Results
Hyler, S. E., Rieder, R. O., Williams, J. B. W., Spitzer, R. L., Hendler, J., & Lyons, M. J. (1988) · Journal of Personality Disorders · doi:10.1521/pedi.1988.2.3.229 · Cited by 293 · see citing works
Effect of Fluoxetine on Anger in Symptomatic Volunteers With Borderline Personality Disorder
Salzman, C., Wolfson, A. N., Schatzberg, A. F., Looper, J., Henke, R., Albanese, M. A., Schwartz, J., & Miyawaki, E. K. (1995) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199502000-00005 · Cited by 279 · see citing works
Melartin, T. K., Rytsala, H. J., Leskela, U. S., Lestela-Mielonen, P. S., Sokero, T. P., & Isometsa, E. T. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0207 · Cited by 260 · see citing works
Comorbidity of personality disorders and depression: Implications for treatment.
Shea, M. T., Widiger, T. A., & Klein, M. H. (1992) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.60.6.857 · Cited by 255 · see citing works
The Range of Impaired Functioning Tool (LIFE–RIFT): a brief measure of functional impairment
Leon, A. C., SOLOMON, D. A., Mueller, T. I., Turvey, C., ENDICOTT, J., & Keller, M. B. (1999) · Psychological Medicine · doi:10.1017/s0033291799008570 · Cited by 228 · see citing works
Jackson, H. J., & Burgess, P. M. (2000) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s001270050276 · Cited by 197 · see citing works
Langbehn, D. R., Pfohl, B. M., Reynolds, S., Clark, L. A., Battaglia, M., Bellodi, L., Cadoret, R., Grove, W., Pilkonis, P., & Links, P. (1999) · Journal of Personality Disorders · doi:10.1521/pedi.1999.13.1.75 · Cited by 147 · see citing works
The Wisconsin Personality Disorders Inventory: Development, Reliability, and Validity
Klein, M. H., Benjamin, L. S., Rosenfeld, R., Treece, C., Husted, J. J., & Greist, J. H. (1993) · Journal of Personality Disorders · doi:10.1521/pedi.1993.7.4.285 · Cited by 147 · see citing works
Grilo, C. M., Sanislow, C. A., Shea, M. T., Skodol, A. E., Stout, R. L., Gunderson, J. G., Yen, S., Bender, D. S., Pagano, M. E., Zanarini, M. C., et al. (2005) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.73.1.78 · Cited by 124 · see citing works
Thomas, S. J., Shin, M., McInnis, M. G., & Bostwick, J. R. (2015) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1576 · Cited by 116 · see citing works
Bipolar Disorder With Comorbid Cluster B Personality Disorder Features
Garno, J. L., Goldberg, J. F., RAMIREZ, P. M., & Ritzler, B. A. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0310 · Cited by 114 · see citing works
Kool, S., Schoevers, R. A., de Maat, S. C. M., Van, R., Molenaar, P. A., Vink, A., & Dekker, J. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.05.017 · Cited by 91 · see citing works
Fluoxetine in borderline personality disorder
Norden, M. J. (1989) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(89)90040-7 · Cited by 89 · see citing works
The Relationship of Personality Disorders to Treatment Outcome in Depressed Outpatients
Mulder, R., Joyce, P. R., & Luty, S. E. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0306 · Cited by 85 · see citing works
Borderline personality disorder in patients with bipolar disorder and response to lamotrigine
Preston, G. A., Marchant, B. K., Reimherr, F. W., Strong, R. E., & Hedges, D. W. (2004) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00358-0 · Cited by 82 · see citing works
Palmer, N. B., Salcedo, J., Miller, A. L., Winiarski, M. G., & Arno, P. S. (2003) · AIDS Patient Care and STDs · doi:10.1089/108729103771928690 · Cited by 72 · see citing works
The DSM-IV and ICD-10 personality questionnaire (DIP-Q): Construction and preliminary validation
Ottosson, H., Bodlund, O., Ekselius, L., von Knorring, L., Kullgren, G., Lindström, E., & Söderberg, S. (1995) · Nordic Journal of Psychiatry · doi:10.3109/08039489509011918 · Cited by 68 · see citing works
Pukrop, R., Gentil, I., Steinbring, I., & Steinmeyer, E. M. (2001) · Journal of Personality Disorders · doi:10.1521/pedi.15.5.450.19195 · Cited by 58 · see citing works
Strakowski, S. M., Stoll, A. L., Tohen, M. F., et al. (1993) · Psychiatry Research · doi:10.1016/0165-1781(93)90107-r · Cited by 51 · see citing works
The prevalence, age distribution and comorbidity of personality disorders in Australian women
Quirk, S. E., Berk, M., Pasco, J. A., Brennan-Olsen, S. L., Chanen, A. M., Koivumaa-Honkanen, H. T., Burke, L. M., Jackson, H. J., Hulbert, C. A., Olsson, C. A., et al. (2016) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867416649032 · Cited by 50 · see citing works
Self-citationA study of relapses in subjects with mood disorder on lithium treatment
Gasperini, M., Scherillo, P., Manfredonia, M. G., Franchini, L., & Smeraldi, E. (1993) · European Neuropsychopharmacology · doi:10.1016/0924-977x(93)90261-j · Cited by 47 · see citing works
Prevalence of Personality Disorders in a General Population Among Men and Women
Gawda, B., & Czubak, K. (2017) · Psychological Reports · doi:10.1177/0033294117692807 · Cited by 41 · see citing works
Sansone, R. A., Bohinc, R. J., & Wiederman, M. W. (2014) · International Journal of Psychiatry in Clinical Practice · doi:10.3109/13651501.2014.988269 · Cited by 29 · see citing works
Dual–Dual Action? Combining Venlafaxine and Mirtazapine in the Treatment of Depression
Malhi, G. S., Ng, F., & Berk, M. (2008) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/00048670701881587 · Cited by 26 · see citing works
Self-citationNon-compliance with pharmacotherapy of depression is associated with a sensation seeking personality
Ekselius, L., Bengtsson, F., & von Knorring, L. (2000) · International Clinical Psychopharmacology · doi:10.1097/00004850-200015050-00004 · Cited by 23 · see citing works
Self and informant report across the borderline personality disorder spectrum.
Balsis, S. M., Loehle-Conger, E., Busch, A., Ungredda, T., & Oltmanns, T. F. (2017) · Personality Disorders Theory Research and Treatment · doi:10.1037/per0000259 · Cited by 22 · see citing works
Personality disorder and population mental health
Quirk, S. E., Williams, L. J., Chanen, A. M., & Berk, M. (2015) · The Lancet Psychiatry · doi:10.1016/s2215-0366(14)00144-8 · Cited by 21 · see citing works
Self-citationPrevalence of axis II comorbidities in bipolar disorder: relationship to mood state
Post, R. M., Leverich, G. S., McElroy, S. L., Kupka, R., Suppes, T. M., Altshuler, L. L., Nolen, W. A., Frye, M. A., Keck, P. E., Grunze, H., et al. (2018) · Bipolar Disorders · doi:10.1111/bdi.12596 · Cited by 21 · see citing works
Platelet MAO, personality and response to lithium prophylaxis
Abou-Saleh, M. T. (1983) · Journal of Affective Disorders · doi:10.1016/0165-0327(83)90037-x · Cited by 19 · see citing works
What's New in Personality Disorders?: An Update on Pharmacologic Treatment
Soloff, P. H. (1990) · Journal of Personality Disorders · doi:10.1521/pedi.1990.4.3.233 · Cited by 18 · see citing works
Cloninger, C. R., & Švrakić, D. M. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-252-6_28 · Cited by 17 · see citing works
The impact of personality disorders on treatment outcome in bipolar disorder: A review
Bieling, P., Green, S. M., & MacQUEEN, G. M. (2007) · Personality and Mental Health · doi:10.1002/pmh.13 · Cited by 12 · see citing works
The influence of personality on the treatment outcome of psychopathology
Mulder, R. (2011) · World Psychiatry · doi:10.1002/j.2051-5545.2011.tb00033.x · Cited by 8 · see citing works
Personality disorder comorbidity among patients with bipolar I disorder in remission
Tamam, L., Özpoyraz, N., & Karataş, G. (2004) · Acta Neuropsychiatrica · doi:10.1111/j.1601-5215.2004.00074.x · Cited by 8 · see citing works
Hengartner, M. P., & Yamanaka, M. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00009 · Cited by 7 · see citing works
Personality Disorders and Treatment: A Therapeutic Conundrum
Eskedal, G. A. (1998) · Journal of Adult Development · doi:10.1023/a:1021458410456 · Cited by 6 · see citing works
Flagged first, then by citations
Research works printed but not linked: 3
- [13]National Institute for Health and Care Excellence. Depression in adults: Recognition and Management: National Institute for Health and Care Excellence, 2009. 31990491
- [61]Covidence Systematic Review Software, Veritas Health Innovation. Melbourne, Australia www.covidence.org
- [66]Review Manager (RevMan) [program]. 5.3 version. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Cited by
Sorted by citations
Time for united action on depression: a Lancet–World Psychiatric Association Commission
Herrman, H., Patel, V., Kieling, C., Berk, M., Buchweitz, C., Cuijpers, P., Furukawa, T. A., Kessler, R. C., Kohrt, B. A., Maj, M., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(21)02141-3 · Cited by 1,104 · see citing works
Self-citation
- Authors
- Kavanagh, B. E., Brennan-Olsen, S. L., Turner, A., Dean, O. M., Berk, M., Ashton, M. M., Koivumaa-Honkanen, H., & Williams, L. J.
- Affiliations
- Barwon Health (AU)
- The University of Melbourne (AU)
- The Royal Melbourne Hospital (AU)
- University of Eastern Finland (FI)
- Corresponding author
- Kavanagh, Bianca E
- ORCID
- Venue
- BMJ Open
- Publisher
- BMJ
- Published
- 2019-04
- Volume
- 9
- Issue
- 4
- Pages
- e025145
- ISSN
- 2044-6055 (ISSN-L)
- PMC
- PMC6502230
- OpenAlex
- W2942715028
- Cited by
- 9
- References
- 68
- Citations by year
- 2023: 2 · 2022: 2 · 2021: 1 · 2020: 4
- FWCI
- 0.28
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- BMJ Open (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- UEF eRepo (University of Eastern Finland) (submittedVersion, cc-by-nc)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc)
- Own your potential (DEAKIN) (submittedVersion)
- Figshare (submittedVersion, cc-by-nc)
- HighWire Press Open Archive (submittedVersion)
- Funders
- Australian Postgraduate Research Training Scholarship
- Australian Society for Bipolar and Depressive Disorders
- Australian Rotary Health
- National Health and Medical Research Council
- Kuopio University Hospital
- Topics
- Social Sciences › Psychology › Clinical Psychology › Personality Disorders and Psychopathology
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Social Sciences › Psychology › Clinical Psychology › Personality Traits and Psychology
- Keywords
- personality disorders, mood disorders, depressive disorders, bipolar spectrum disorders, pharmacological interventions, antidepressants, antipsychotic drugs, treatment outcomes, comorbidities, remission
- MeSH terms
- Adult, Antidepressive Agents, Tricyclic, Humans, Personality Disorders, Review Literature as Topic, Meta-Analysis as Topic, Randomized Controlled Trials as Topic, Treatment Outcome, Selective Serotonin Reuptake Inhibitors, Mood Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
